1910 Genetics

Private Company

Advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.

Biotechnology Research
Boston, MA
11-50 employees
Founded May 2018

About 1910 Genetics

1910 Genetics pioneers therapeutics discovery by integrating advanced AI, multimodal data, and high-throughput lab automation. The company provides an end-to-end AI platform and collaborative services to accelerate the design of small and large molecule drugs. It primarily serves pharmaceutical and biotechnology organizations, aiming to enhance R&D productivity and shorten drug development timelines.

Company Classification

Customer Types
B2B
Business Models
ServicesLicensing
Product & Service Types
AI Drug Discovery PlatformCollaborative R&D ServicesFederated Learning Solutions

Funding

Total Funding

$26.65M

No. of Funding Rounds

5

Customers

CustomerSuccess StorySource
Accenture
Collaborated with 1910 Genetics to help biopharma companies transform drug discovery by integrating Accenture’s AI expertise with 1910’s end‑to‑end AI platform.
Genentech
1910 Genetics applied its integrated AI drug discovery platform to identify and optimize novel lead compounds against a Genentech‑selected immuno‑oncology target.
Nice Try
Sign up to Ethos to access the full customer list
Sign up to Ethos
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.Source
Another Company
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Source
One More Company
Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sunt in culpa qui officia deserunt mollit anim id est laborum.Source
Nice Try
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.Source

Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.

Sign up to Ethos